Endocrinology

  • 2020 ACOI Annual Convention and Scientific Sessions

    Contains 61 Product(s)

    This course is certified for 52 AOA Category 1A CME credits. Recordings from the 2020 ACOI Annual Convention and Scientific Sessions, held October 21 - October 24, 2020.

  • Filtering Out the Potential Role of SGLT2 Inhibitors for the Management of CKD

    Contains 4 Component(s), Includes Credits Recorded On: 10/23/2020

    This activity is certified for .75 AOA 1-A Credit. Recorded October 23, 2020. Brief review of CKD burden in the US and an overview of cardiorenal syndrome. The effects of SGLT2 inhibitors on renal outcomes will be summarized. Explore the potential mechanisms by which these medications exert their renoprotective effects. Review completed and on-going CKD trials with SGLT2 inhibitors.

  • New Diabetes Medicine: Protecting the Heart or Hyperbole?

    Contains 4 Component(s), Includes Credits Recorded On: 10/22/2020

    This activity is certified for 0.5 AOA 1-A Credit. Recorded October 22, 2020. Explore how newer diabetes medications deliver clinical benefits beyond glucose lowering, including cardiovascular risk reduction and benefits for patients with heart failure and/or chronic kidney disease.

  • New Strategies for Thyroid and Diabetes Testing

    Contains 4 Component(s), Includes Credits Recorded On: 10/22/2020

    This activity is certified for 1.00 AOA 1-A Credit. Recorded October 22, 2020. Summarize test selection, timing, and monitoring for patients with thyroid and/or glucose dysfunctions.

  • Improving Diabetic Health of Populations

    Contains 4 Component(s), Includes Credits Recorded On: 10/22/2020

    This activity is certified for 0.75 AOA 1-A Credit. Recorded October 22, 2020. Assess the population health challenges associated with diabetes. Summarize diagnostic, treatment, and monitoring options across the spectrum of patient needs.